Cross-Sector entity
Cyclospora cayetanensis is the most frequent co-covered peer, appearing in 2 of the 3 tracked stories. regulation accounts for 2 of the 3 tracked stories, while 1 other category carries the remainder. Across an 8-day span, the pace is roughly 2.6 stories per week.
3 verified stories tracked
Last mentioned: Jul 19, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 33 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Cyclospora cayetanensis is the most frequent co-covered peer, appearing in 2 of the 3 tracked stories. regulation accounts for 2 of the 3 tracked stories, while 1 other category carries the remainder. Across an 8-day span, the pace is roughly 2.6 stories per week. Each carries 9 original sources on average. This profile follows 3 Cross-Sector stories mentioning Dr. Natasha Bagdasarian across the period from July 12, 2026 to July 19, 2026.
Computed from the 3 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Dr. Natasha Bagdasarian. Shared-story counts are live from our verified record — not editorial picks.
As the diarrheal illness sweeps the state, health officials stress early testing for Cyclospora in patients with persistent symptoms, noting treatment with antibiotics is effective but diagnostic challenges persist.
Source: wwmt.com · ktok.iheart.com
A cyclosporiasis outbreak in Michigan has surpassed 2,000 cases, with early investigations singling out lettuce or salad greens as the common factor. Health officials are advising against prepackaged salads, and clinicians should be prepared for patients presenting with prolonged, watery diarrhea.
Source: 710wor.iheart.com · kogo.iheart.com
With 992 infections in Michigan, the cyclospora outbreak creates urgent demand for antibiotic supplies and spotlights the need for novel antiparasitic therapies, presenting both short-term and long-term opportunities for biopharma.
Source: sandiegouniontribune.com · orlandosentinel.com
